The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Advantage 250 Spot-on solution for Dogs



Elanco GmbHVPA22020/046/003

Main Information

Trade NameAdvantage 250 Spot-on solution for Dogs
Active SubstancesImidacloprid
Dosage FormSpot-on solution
Licence HolderElanco GmbH
License Holder AddressHeinz-Lohmann-Strasse 4
27472 Cuxhaven
Germany
Licence NumberVPA22020/046/003

Group Information

ATC CodeQP53AX17 imidacloprid
Therapeutic ClassEctoparasiticide
SpeciesDogs

Status

License statusAuthorised
Licence Issued23/02/2001
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back